Dual Buffett Strategy
Forbes - NY,USA
In 2005, the company pulled its multiple sclerosis drug, Tysabri, from the market after a patient who was taking the drug in conjunction with another ...
See all stories on this topic

Rough Week for Biotech
Seeking Alpha - New York,NY,USA
It was even more negative than the week in early 2005 when Tysabri was pulled from the market, a week that saw only a 4.5% drop. ...
See all stories on this topic